Related by context. Frequent words. (Click for all words.) 60 Inc. Nasdaq IMGN 59 Neogenix 59 ImmunoCellular Therapeutics 58 Edward Lanphier Sangamo 58 MultiCell Technologies 57 Acumen BioFin Rodman 57 Annual BIO 57 GammaCan 57 Inovio Pharmaceuticals 57 Preclinical Development 57 Elixir Pharmaceuticals 56 Vaccinex 56 Regado Biosciences 56 Peptimmune 56 Bayhill Therapeutics 56 BIOCOM Investor Conference 56 MedNet Solutions 56 BIO InvestorForum 56 Genaera Corporation 56 Senesco Technologies 56 Nasdaq KERX 56 ANAVEX 56 Martin Madaus 56 Cerus Corporation 56 Therapeutic Competitors 55 Chemokine Therapeutics 55 Agios Pharmaceuticals 55 ZIOPHARM Oncology Inc. 55 Callisto Pharmaceuticals 55 Exploit collaboration 55 Sol J. Barer 55 Nasdaq ENZN 55 Dino Dina 55 Metabasis Therapeutics Inc. 55 Files Shelf Registration Statement 55 FluoroPharma 55 Nasdaq AEZS 55 Inc Therapeutic Competitors 55 BioFinance 55 PhytoMedical Technologies Inc. 54 Æterna Zentaris 54 Tranzyme Pharma 54 Genitope Corporation 54 AVEO Pharmaceuticals 54 Humanetics 54 Diatos 54 Chief ExecutiveOfficer 54 Idenix Pharmaceuticals 54 Arthur S. Przybyl 54 Power3 Medical 54 Idera Pharmaceuticals 54 Aegera 54 TapImmune 54 CardioVascular BioTherapeutics Inc. 54 Simon Sturge 53 Webcast Presentations 53 ISTO 53 Nanobiotix 53 Amorcyte 53 Celator 53 NASDAQ SLXP today 53 Odyssey Thera 53 NanoViricides 53 LD Micro 53 ARIAD Pharmaceuticals Inc. 53 Quark Pharmaceuticals 53 VIA Pharmaceuticals 53 Applied NeuroSolutions 53 Cambridge Healthtech Institute 53 Jack Lief 53 Ambit Biosciences 53 Epizyme 53 Undiscovered Equities 53 JMP Securities Healthcare 53 Receptos 53 ExonHit Therapeutics 52 Upcoming Conferences 52 Neuro Hitech 52 Optimata 52 Aegerion 52 Ligand Pharmaceuticals Incorporated 52 Chemokine 52 Emisphere Technologies 52 Cempra 52 PRNewswire FirstCall Medarex 52 NASDAQ ARIA 52 Jumps Higher 52 Hyperion Therapeutics 52 Endovasc 52 Angiochem 52 Nasdaq ADLR 52 Nasdaq DNDN 52 ProtoKinetix 52 Announces Postponement 52 Euroscreen 51 OPKO Health 51 Flamel Technologies 51 TransMolecular 51 Oncolin 51 Sinobiomed 51 PRNewswire FirstCall Keryx Biopharmaceuticals